+44 (0)203 011 5574 info@orthocg.com
Leading U.S. Virtual Reality Surgical Training Company, Osso VR, Officially Expands to Europe

Leading U.S. Virtual Reality Surgical Training Company, Osso VR, Officially Expands to Europe

PALO ALTO, Calif. – April 9, 2019 – Osso VR, the only scientifically validated virtual reality surgical training platform, today announces its official expansion into the European market after Newcastle Hospital’s Simulation Centre has begun using the technology to prepare surgeons for difficult procedures.

The European healthcare market is facing growing challenges training new surgeons.  According to a report from the Royal College of Surgeons, surgical trainees were focused more on service tasks, such as administrative work, instead of participating in patient care. Additionally, changing dynamics within training have resulted in less hands-on experiences moving them to later in the training process. Due to these challenges and the rapid availability of new technology even practiced surgeons are finding it difficult to keep up.

“Newcastle Hospital has the widest adoption of robotic and minimally invasive surgery in the UK,” said Naeem Soomro, director of robotic surgery at Newcastle Hospital. “At Newcastle Surgical Training Centre, we deliver around 300 surgical courses each year and believe that VR/AR along with realistic simulation will become a significant component of surgical training in the future and are very pleased to partner with Osso VR.”

Osso VR has seen success across the U.S. in top residency programs looking to increase access to hands-on training and assessment opportunities for surgical trainees. The company has also attracted top orthopedic medical device companies to use the platform to improve training, encourage safe use, and increase adoption of their devices. In scientifically validating the platform, preliminary study results have shown the Osso VR-trained group performed 230 percent better than the control group, trained traditionally, as measured by the Global Rating Scale.

“Surgical skill is directly correlated with patient outcomes, yet we don’t currently measure the proficiency of our surgical care providers. Ideally we can identify improvement areas and then intervene with targeted simulation in order to provide higher quality and standardized care around the globe.,” said Justin Barad, MD and CEO/co-founder of Osso VR. “Immersive technologies like VR have the proven ability to address the challenges presented by the current the accelerating pace of innovation. We are thrilled to be working globally with more hospitals and device companies that understand that the biggest problem we’re facing today is not what we are doing for our patients, but how we are doing it.”

“We see VR as an integral cog in the development and maintenance of surgical skills acquisition in health care education,” said Paul Fearon, training programme director in orthopaedics at Newcastle Hospital. “It interfaces with high fidelity simulation, allowing team-based learning with the ultimate goal of improving patient safety.”

Osso VR augments the apprenticeship training model the surgical education system has relied on for over a century, and addresses the shortcomings presented by traditional one-to-two day workshops for medical device companies. One way Osso VR does this is by objectively allowing multiple surgeons to train together in one VR space independent of their physical location. Collaborative training affords improved learning and assessment opportunities for surgeons and the surgical team, as well as gives medical device companies more scalable way to offer workshops and training sessions.  

Osso VR also allows for surgical proficiency to finally be easily and objectively measured. Currently, assessment of surgical performance is rarely performed and, when it is, is quite subjective. Analytics and data provided on each surgeon’s allows users to identify improvement opportunities and see how they are doing in relation to their peers.

To learn more about Osso VR, visit www.ossovr.com.

About Osso VR

Osso VR is an award-winning, clinically validated surgical training platform designed for medical device companies, practicing surgeons, residents and medical students of all skill levels. Using immersive VR technology, the platform offers a highly realistic training environment in order to improve patient outcomes. Osso VR is the first training platform to incorporate assessment into its modules, objectively measuring the trainee’s knowledge of steps, level of precision and overall efficiency throughout the procedure providing a benchmark for proficiency.

Led by UCLA and Harvard trained orthopedic surgeon Justin Barad, MD, the Osso VR team has a deep background in clinical care, medical technology, and VR development. To learn more, visit www.ossovr.com.

Ortho Consulting Group Partners with Imperial College London for the Next Imperial MedTech Event – ‘Innovation in Musculoskeletal Technologies’

Ortho Consulting Group Partners with Imperial College London for the Next Imperial MedTech Event – ‘Innovation in Musculoskeletal Technologies’

NEWBURY, England, April 4, 2019 /PRNewswire/ — Ortho Consulting Group is proud to be partnering with the ‘Innovations in Musculoskeletal Technologies’ event at Imperial College London, on Friday 26th April 2019.

This is the latest event in the ‘Imperial MedTech Links Series’ and exhibits the most recent development in technologies for Musculoskeletal Medicine. Imperial College researchers and clinicians will be showcasing their work and giving talks on biomaterials, regenerative medicine, technologies for rehabilitation and surgical technologies for orthopaedics.

Matt Woods, Founder of Ortho Consulting Group, said: “I’m proud to be partnering with this event and with Imperial College to support their work. New technology in medicine is crucial to the successful future of the orthopaedic industry. Ortho Consulting Group is passionate about getting the very best products to orthopaedic patients worldwide, and this event showcases some of the best in innovative solutions in musculoskeletal.”

The event takes place at Imperial College’s South Kensington Campus, London, and runs from 13:00 (with lunch) until 20:00. For further details please visit http://www.imperial.ac.uk/medtech/

About Ortho Consulting Group

With a network of over 5,000 validated contacts, Ortho Consulting Group (OCG) are a team of industry experts specialising in global strategy and building, strengthening and managing global sales channels, specifically outside of the US.

OCG understand the challenges of growing a global business within Orthopaedics and Spine and offers a holistic consultancy service to advise, support and deliver orthopaedic manufacturers’ expansion strategies.

Made up of two specialist divisions, Orthoconnections and Orthoexecutive, OCG can cover all sales channel expansion solutions, whether that’s growing and onboarding your senior leadership team or sourcing and managing your distributors.

About Imperial MedTech Links

Imperial MedTech Links promotes and supports interactions between companies in the medical technology sector and Imperial College scientists, engineers and clinicians in the biomedical engineering field. The 26th April event celebrates innovative work in the field of musculoskeletal technologies. http://www.imperial.ac.uk/medtech/events/

Further information

Full information about this event is available at:  http://www.imperial.ac.uk/medtech/events/

Media contact:

Tom Edwards, Group Marketing Manager
Ortho Consulting Group 
tomedwards@orthocg.com 

SOURCE Ortho Consulting Group

Innovations in Musculoskeletal Technologies 26th April

Innovations in Musculoskeletal Technologies 26th April

March 29th, 2019 LONDON

Imperial College researchers share the latest developments in technologies for musculoskeletal medicine.  Work on biomaterials, regenerative medicine, technologies for rehabilitation and surgical technologies for orthopaedics will bring new tools to surgery, to wound healing and to rehabilitation.

Imperial’s engineers, scientists and clinicians work with industry to translate cutting edge research into products and services for patients.  The 26th April’s Innovations in MSK Technologies event highlights exciting developments to a key audience of industry partners from around the world.  Professor Anthony Bull, Professor of Musculoskeletal Mechanics and Head of the Department of Bioengineering, will introduce work from colleagues and collaborators from across the College and from amongst our spin-off and start-up companies.

Where and when:

This is the latest in the Imperial MedTech Links series and will take place in Imperial College’s South Kensington campus in central London on Friday 26th April 1-8pm.

Further Information:

Full information about this event is available at: http://www.imperial.ac.uk/medtech/events/

Contact:

Robert Ferguson, Industrial Liaison Manager, Dept. of Bioengineering, Imperial College:

Email: robert.ferguson@imperial.ac.uk.  Tel: 020 7594 6371

Imperial College MedTech Links

Event Sponsor

Brainlab Acquires Robotics Platform Company Medineering

Brainlab Acquires Robotics Platform Company Medineering

Brainlab creates first openly scalable medical robotics platform paired with an efficient software ecosystem

MUNICH–(BUSINESS WIRE)–Brainlab, a global pioneer of software-driven medical technology, announced today the acquisition of Medineering, a developer of application-specific robotic technologies. With this move, Brainlab is driving the democratization of digital surgery with scalable solutions that expand clinical frontiers.

This strategic move increases the depth of the Brainlab portfolio in cranial surgery and strengthens its offering in spinal surgery, contributing a powerful digital step in clinical workflows. Brainlab currently markets the Medineering arm under the name Cirq®. Inspired by the form of the human arm, Cirq is an intuitive assistant during surgical procedures. After quick setup, highly adaptable Cirq can be aligned in seven degrees of freedom for maximum positioning flexibility. Once Cirq is locked firmly in place, surgeons are free to focus on subsequent surgical steps with both hands. Navigation integration leverages established workflows, set-up and instrumentation, and extends utilization. The combination of a base arm and attachable “hand” modules makes Cirq scalable and future-proof.

The acquisition adds another platform to the open hardware architecture of the Brainlab digital ecosystem for surgery, enabling other medical technology companies to design their own solutions and applications across many subspecialties. Unlike other closed monolithic industry offerings, this acquisition is expected to offer an open platform for a broad range of clinical opportunities.

Brainlab has been an investor and distribution partner for Medineering for nearly three years. In contrast to robotics concepts that start at over a million dollars, the light weight Medineering arm is available for a fraction of the cost and mounts easily to the siderails of the O.R. table, making the vendor-neutral robotic platform accessible to many of the over 4,000 existing Brainlab customers, and expanding market reach into ambulatory surgery centers. Medineering has demonstrated the feasibility of its mechatronic arm for holding a range of hands, from a straightforward instrument holder to robotic hands for the alignment of biopsy needles, drill guides, and endoscopes. Several applications are already available and in clinical use in Europe, under the name Cirq, with FDA clearance pending in the United States.

“Becoming part of Brainlab means scalability for our technology and improved market access,” comments Stephan Nowatschin, Co-Founder and CEO, Medineering. “Combining our open platform with the software ecosystem from Brainlab will enable more efficient development of very competitive clinical solutions.”

“Medineering introduced a fresh new approach to surgical robotics when we entered into our partnership less than three years ago,” said Stefan Vilsmeier, President and CEO, Brainlab. Today, we are shifting gears and accelerating development with additional resources to address a broader clinical market.”

About Brainlab

Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 12,850 systems installed in over 100 countries. Brainlab employs almost 1,400 people in 18 offices worldwide, including more than 420 research and development engineers, who form a crucial part of the product development team.

About Medineering

Medineering, headquartered in Munich, develops, manufactures and markets an application-specific and convenient robotic portfolio. The portfolio consists of the Medineering Positioning Arm and compact application-specific robots assisting surgeons in complex anatomical regions. Dr. Maximilian Krinninger and Dr. Stephan Nowatschin founded Medineering in June 2014. The startup has grown rapidly and the young and international team consists of highly specialized robotic engineers, marketing experts and regulatory specialists.

Contacts

Media Contact
Debbra Verard
Brainlab
+1 914-602-4589
Debbra.verard@brainlab.com

SOURCE: BusinessWire March 20, 2019

Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors

Centinel Spine Appoints Dirk M. Kuyper and Gregory Rainey to its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ — Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced the appointment of Dirk M. Kuyper and Gregory Rainey as members of the Company’s Board of Directors.

“I am thrilled to welcome both Dirk and Gregory to the Centinel board,” says Centinel Spine Chairman & CEO, John Viscogliosi.  “Both individuals bring a wealth of achievement across the industry and decades of proven leadership success that will complement an already experienced board.  I am anticipating that these additions will bring significant value as we push forward in meeting short-term business goals as well as our corporate mission to become the worldwide leading company addressing spinal disease anteriorly.”

Dirk M. Kuyper has had a long and successful career in medical device companies, with his efforts focused on development and implementation of strategy and revenue growth.  Mr. Kuyper is currently the Owner and CEO of Precision Machinists Company, Inc., a manufacturing firm specializing in precision CNC components for the semiconductor, aerospace, and medical device markets. Prior to this, he served as President and CEO of Illuminoss Medical, Inc., a privately-held medical device company specializing in minimally invasive, patient customized orthopedic implants for the treatment of bone fractures. From 2007 to 2012, Mr. Kuyper served as the President & CEO, and as a member of the board of directors, of Alphatec Spine, Inc.  Prior to his work for Alphatec, he served in several executive capacities as President, Executive Vice President, and as Chief Operating Officer for Aesculap, Inc., a division of B. Braun Medical. Since 2013, Mr. Kuyper has served as an independent director, chair of the compensation, and a member of the nominating and governance committees of Conmed Corporation.

Gregory Rainey is currently principal of CCI Performance Group, a consulting firm that he founded in 2004 to take advantage of his extensive knowledge and experience in the healthcare industry.  He utilizes comprehensive insight and versatility within the healthcare industry to deliver sustainable business solutions for leading Fortune 500 client companies, as well as start-up ventures.  Previously, Mr. Rainey spent more than a decade with Stryker Corporation, as Vice President of Sales for the Orthopedic Division.  He led the national sales organization to overall sales growth of $425 million in four years, and his leadership was integral toward catapulting the organization from the fourth to the first-rated, fastest-growing company in the industry.  Mr. Rainey’s earlier career successes span tenures with multiple companies, including Joint Medical Corporation and U.S. Surgical Corporation.  He currently sits on the public board of CAS Medical (CASM), where he serves as Chairman of the Governance Committee, and also serves on the Board of Directors for Catalyst Orthoscience.  Mr. Rainey previously sat on the public board of RTI Surgical (RTIX).

“The combined experience of Dirk and Gregory brings an additional level of diversity to the board, which is extremely valuable to our team,” says Viscogliosi. “I welcome both of these high caliber leaders and look forward to working with them.”

About Centinel Spine, LLC

Centinel Spine®, LLC is the largest privately-held spine company focused on anterior column reconstruction. The company offers a continuum of trusted, brand-name motion-preserving and fusion solutions backed by over 30 years of clinical success — providing the most robust and clinically-proven Total Disc Replacement and Integrated Interbody™ portfolios in the world.

The company began operations in 2008 through the merger-acquisition of two pioneering medical device companies—Raymedica, LLC and Surgicraft, LTD. UK-based Surgicraft launched the first Stand-Alone/No Profile® anterior lumbar interbody fusion device in the world in 1988, which was the basis for future generations of the market-leading Integrated Interbody™ technology platform known today as STALIF®. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission to become the worldwide leading company addressing spinal disease anteriorly with the widest breadth & depth of technology platforms.

The company recently acquired the prodisc® Total Disc Replacement Technology Platform—the most extensive cervical and lumbar motion-preserving reconstruction portfolio available today.   With the addition of prodisc, Centinel Spine stands alone as the only company with comprehensive motion-preserving and fusion solutions for both cervical and lumbar anterior column reconstruction.

Centinel Spine derived its name from the “Sentinel Sign”, the radiographic confirmation of a successful fusion anterior to the interbody device.

For more information, please visit the company’s website at www.CentinelSpine.com or contact:

Varun Gandhi
SVP, Corporate Finance & Strategic Planning 
900 Airport Road, Suite 3B
West Chester, PA 19380
Phone: 484-887-8871
Email: v.gandhi@centinelspine.com

SOURCE Centinel Spine, LLC